HDFC Mutual Fund Expands Stake in Global Health with ₹130 Crore Deal

HDFC Mutual Fund has significantly increased its footprint in the healthcare sector by acquiring an additional 10 lakh shares of Global Health, the operator of the renowned Medanta hospital chain. This strategic move underscores the fund house's growing confidence in the company's long-term growth trajectory and robust financial performance.

Strengthening the Stake through Open Market Transactions

In a substantial block deal executed through the Bombay Stock Exchange (BSE), HDFC Mutual Fund purchased 10 lakh shares of Global Health at an average price of ₹1,300 per share. This transaction, valued at approximately ₹130 crore, represents a 0.37 per cent stake in the company.

The shares were acquired from Sunil Sachdeva, a co-founder of Medanta Hospitals, who offloaded the equity at the same price point. This follows a similar transaction last month, where HDFC Mutual Fund had already purchased 10 lakh shares from Sachdeva for a consideration of over ₹122 crore. As of the end of the March quarter, Sachdeva held a significant stake of 2.90 crore equity shares, accounting for 10.79 per cent of Global Health.

Robust Financial Performance Drives Investor Interest

The intensified interest from institutional investors like HDFC Mutual Fund comes on the heels of impressive quarterly results reported by Global Health. The company has demonstrated strong momentum in both top-line and bottom-line growth, signaling high operational efficiency.

For the fourth quarter ended March 31, 2026, Global Health reported a significant 39.7 per cent surge in Profit After Tax (PAT), reaching ₹141.7 crore. This is a notable jump from the ₹101.4 crore profit posted in the same quarter of the previous fiscal year. Furthermore, the company’s revenue from operations saw a healthy rise to ₹1,159 crore, compared to ₹931.3 crore in the corresponding period last year.

Market Reaction and Sector Outlook

Despite the large-scale block deal, the broader market showed a slightly cautious stance toward the stock on the day of the transaction. Shares of Global Health witnessed a marginal decline of 0.41 per cent, closing at ₹1,311.35 on the BSE.

The continuous accumulation of shares by a major player like HDFC Mutual Fund suggests that institutional investors are betting on the scalability of the Medanta brand and the increasing demand for organized healthcare services in India. As the healthcare sector continues to evolve, companies with strong revenue growth and consistent profitability are likely to remain preferred targets for large-scale institutional capital.

Key Takeaways

  • Increased Exposure: HDFC Mutual Fund acquired a 0.37% stake in Global Health through a ₹130 crore deal, marking its second major purchase from co-founder Sunil Sachdeva in two months.
  • Strong Earnings Growth: Global Health reported a 39.7% increase in quarterly PAT to ₹141.7 crore, backed by a rise in operational revenue to ₹1,159 crore.
  • Institutional Confidence: The recurring block deals highlight a strategic institutional move to build a position in a high-growth healthcare entity with strong financial fundamentals.